Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma
Background Immune checkpoint inhibitor (ICI)-based regimens can be associated with prolonged survival and disease control after treatment discontinuation without further anticancer therapy. An integrated, comprehensive partitioned survival analysis describes how patients spend overall survival (OS)...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2026-01-01
|
| Col·lecció: | Journal for ImmunoTherapy of Cancer |
| Accés en línia: | https://jitc.bmj.com/content/14/1/e013546.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|